ENDONOVO THERAPEUTICS, INC. (ENDV) Operating margin 2013–2022
ENDONOVO THERAPEUTICS, INC. (ENDV) operating margin by fiscal year — reported operating income divided by reported revenue.
-2411.7%FY2022 · since FY2013: -10607.6% → -2411.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -2411.7% | +634.0 pp |
| FY2021 | -3045.7% | -1289.2 pp |
| FY2020 | -1756.5% | -528.4 pp |
| FY2019 | -1228.1% | +3767.2 pp |
| FY2018 | -4995.3% | — |
| FY2015 | -60132.7% | -51075.1 pp |
| FY2014 | -9057.6% | +1550.1 pp |
| FY2013 | -10607.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice